Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Combination Vaccines for Children Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Combination Vaccines for Children Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-08-01

Pages: 80 Pages

Report ld: 4828746

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Combination Vaccines for Children market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Combination Vaccines for Children market competitiveness, regional economic performance, and supply chain configurations.

Combination vaccines for children are vaccines that combine multiple vaccines into a single shot. This allows children to receive protection against multiple diseases with fewer injections, reducing the number of shots they need to receive. Combination vaccines are safe and effective, and are recommended by healthcare providers as part of the routine childhood vaccination schedule. Examples of combination vaccines for children include the DTaP vaccine (which protects against diphtheria, tetanus, and pertussis), the MMR vaccine (which protects against measles, mumps, and rubella), and the Hib vaccine (which protects against Haemophilus influenzae type b).

The Combination Vaccines for Children Market is experiencing a growing trend, with major sales regions including North America, Europe, and Asia Pacific. The market is witnessing a high concentration of key players offering a wide range of combination vaccines for children, which is driving market growth. There are significant opportunities in the market, such as increasing awareness about the importance of vaccination, government initiatives to promote immunization programs, and advancements in vaccine technology. However, the market also faces challenges such as stringent regulatory requirements, high costs associated with vaccine development, and vaccine hesitancy among some parents. Overall, the Combination Vaccines for Children Market is poised for continued growth in the coming years.

The global Combination Vaccines for Children market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

GlaxoSmithKline (GSK)
Merck（Sanofi）
Mitsubishi Tanabe Pharma
KM Biologics
Walvax Biotechnology
Biokangtai
Sinovac

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

DTaP
MMR
Others

Segment by Application

Hospital
Clinic
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Combination Vaccines for Children market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., MMR in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinic in India).

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Combination Vaccines for Children value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Combination Vaccines for Children Product Scope

1.2 Combination Vaccines for Children by Type

1.2.1 Global Combination Vaccines for Children Sales by Type (2020 & 2024 & 2031)

1.2.2 DTaP

1.2.3 MMR

1.2.4 Others

1.3 Combination Vaccines for Children by Application

1.3.1 Global Combination Vaccines for Children Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Combination Vaccines for Children Market Estimates and Forecasts (2020-2031)

1.4.1 Global Combination Vaccines for Children Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Combination Vaccines for Children Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Combination Vaccines for Children Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Combination Vaccines for Children Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Combination Vaccines for Children Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Combination Vaccines for Children Sales Market Share by Region (2020-2025)

2.2.2 Global Combination Vaccines for Children Revenue Market Share by Region (2020-2025)

2.3 Global Combination Vaccines for Children Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Combination Vaccines for Children Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Combination Vaccines for Children Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Combination Vaccines for Children Market Size and Prospective (2020-2031)

2.4.2 Europe Combination Vaccines for Children Market Size and Prospective (2020-2031)

2.4.3 China Combination Vaccines for Children Market Size and Prospective (2020-2031)

2.4.4 Japan Combination Vaccines for Children Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Combination Vaccines for Children Historic Market Review by Type (2020-2025)

3.1.1 Global Combination Vaccines for Children Sales by Type (2020-2025)

3.1.2 Global Combination Vaccines for Children Revenue by Type (2020-2025)

3.1.3 Global Combination Vaccines for Children Price by Type (2020-2025)

3.2 Global Combination Vaccines for Children Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Combination Vaccines for Children Sales Forecast by Type (2026-2031)

3.2.2 Global Combination Vaccines for Children Revenue Forecast by Type (2026-2031)

3.2.3 Global Combination Vaccines for Children Price Forecast by Type (2026-2031)

3.3 Different Types Combination Vaccines for Children Representative Players

4 Global Market Size by Application

4.1 Global Combination Vaccines for Children Historic Market Review by Application (2020-2025)

4.1.1 Global Combination Vaccines for Children Sales by Application (2020-2025)

4.1.2 Global Combination Vaccines for Children Revenue by Application (2020-2025)

4.1.3 Global Combination Vaccines for Children Price by Application (2020-2025)

4.2 Global Combination Vaccines for Children Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Combination Vaccines for Children Sales Forecast by Application (2026-2031)

4.2.2 Global Combination Vaccines for Children Revenue Forecast by Application (2026-2031)

4.2.3 Global Combination Vaccines for Children Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Combination Vaccines for Children Application

5 Competition Landscape by Players

5.1 Global Combination Vaccines for Children Sales by Players (2020-2025)

5.2 Global Top Combination Vaccines for Children Players by Revenue (2020-2025)

5.3 Global Combination Vaccines for Children Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Combination Vaccines for Children as of 2024)

5.4 Global Combination Vaccines for Children Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Combination Vaccines for Children, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Combination Vaccines for Children, Product Type & Application

5.7 Global Key Manufacturers of Combination Vaccines for Children, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Combination Vaccines for Children Sales by Company

6.1.1.1 North America Combination Vaccines for Children Sales by Company (2020-2025)

6.1.1.2 North America Combination Vaccines for Children Revenue by Company (2020-2025)

6.1.2 North America Combination Vaccines for Children Sales Breakdown by Type (2020-2025)

6.1.3 North America Combination Vaccines for Children Sales Breakdown by Application (2020-2025)

6.1.4 North America Combination Vaccines for Children Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Combination Vaccines for Children Sales by Company

6.2.1.1 Europe Combination Vaccines for Children Sales by Company (2020-2025)

6.2.1.2 Europe Combination Vaccines for Children Revenue by Company (2020-2025)

6.2.2 Europe Combination Vaccines for Children Sales Breakdown by Type (2020-2025)

6.2.3 Europe Combination Vaccines for Children Sales Breakdown by Application (2020-2025)

6.2.4 Europe Combination Vaccines for Children Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Combination Vaccines for Children Sales by Company

6.3.1.1 China Combination Vaccines for Children Sales by Company (2020-2025)

6.3.1.2 China Combination Vaccines for Children Revenue by Company (2020-2025)

6.3.2 China Combination Vaccines for Children Sales Breakdown by Type (2020-2025)

6.3.3 China Combination Vaccines for Children Sales Breakdown by Application (2020-2025)

6.3.4 China Combination Vaccines for Children Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Combination Vaccines for Children Sales by Company

6.4.1.1 Japan Combination Vaccines for Children Sales by Company (2020-2025)

6.4.1.2 Japan Combination Vaccines for Children Revenue by Company (2020-2025)

6.4.2 Japan Combination Vaccines for Children Sales Breakdown by Type (2020-2025)

6.4.3 Japan Combination Vaccines for Children Sales Breakdown by Application (2020-2025)

6.4.4 Japan Combination Vaccines for Children Major Customer

6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 GlaxoSmithKline (GSK)

7.1.1 GlaxoSmithKline (GSK) Company Information

7.1.2 GlaxoSmithKline (GSK) Business Overview

7.1.3 GlaxoSmithKline (GSK) Combination Vaccines for Children Sales, Revenue and Gross Margin (2020-2025)

7.1.4 GlaxoSmithKline (GSK) Combination Vaccines for Children Products Offered

7.1.5 GlaxoSmithKline (GSK) Recent Development

7.2 Merck（Sanofi）

7.2.1 Merck（Sanofi） Company Information

7.2.2 Merck（Sanofi） Business Overview

7.2.3 Merck（Sanofi） Combination Vaccines for Children Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Merck（Sanofi） Combination Vaccines for Children Products Offered

7.2.5 Merck（Sanofi） Recent Development

7.3 Mitsubishi Tanabe Pharma

7.3.1 Mitsubishi Tanabe Pharma Company Information

7.3.2 Mitsubishi Tanabe Pharma Business Overview

7.3.3 Mitsubishi Tanabe Pharma Combination Vaccines for Children Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Mitsubishi Tanabe Pharma Combination Vaccines for Children Products Offered

7.3.5 Mitsubishi Tanabe Pharma Recent Development

7.4 KM Biologics

7.4.1 KM Biologics Company Information

7.4.2 KM Biologics Business Overview

7.4.3 KM Biologics Combination Vaccines for Children Sales, Revenue and Gross Margin (2020-2025)

7.4.4 KM Biologics Combination Vaccines for Children Products Offered

7.4.5 KM Biologics Recent Development

7.5 Walvax Biotechnology

7.5.1 Walvax Biotechnology Company Information

7.5.2 Walvax Biotechnology Business Overview

7.5.3 Walvax Biotechnology Combination Vaccines for Children Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Walvax Biotechnology Combination Vaccines for Children Products Offered

7.5.5 Walvax Biotechnology Recent Development

7.6 Biokangtai

7.6.1 Biokangtai Company Information

7.6.2 Biokangtai Business Overview

7.6.3 Biokangtai Combination Vaccines for Children Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Biokangtai Combination Vaccines for Children Products Offered

7.6.5 Biokangtai Recent Development

7.7 Sinovac

7.7.1 Sinovac Company Information

7.7.2 Sinovac Business Overview

7.7.3 Sinovac Combination Vaccines for Children Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Sinovac Combination Vaccines for Children Products Offered

7.7.5 Sinovac Recent Development

8 Combination Vaccines for Children Manufacturing Cost Analysis

8.1 Combination Vaccines for Children Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Combination Vaccines for Children

8.4 Combination Vaccines for Children Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Combination Vaccines for Children Distributors List

9.3 Combination Vaccines for Children Customers

10 Combination Vaccines for Children Market Dynamics

10.1 Combination Vaccines for Children Industry Trends

10.2 Combination Vaccines for Children Market Drivers

10.3 Combination Vaccines for Children Market Challenges

10.4 Combination Vaccines for Children Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Combination Vaccines for Children Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Combination Vaccines for Children Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Combination Vaccines for Children Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Combination Vaccines for Children Sales (K Units) by Region (2020-2025)

Table 5. Global Combination Vaccines for Children Sales Market Share by Region (2020-2025)

Table 6. Global Combination Vaccines for Children Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Combination Vaccines for Children Revenue Share by Region (2020-2025)

Table 8. Global Combination Vaccines for Children Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Combination Vaccines for Children Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Combination Vaccines for Children Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Combination Vaccines for Children Revenue Share Forecast by Region (2026-2031)

Table 12. Global Combination Vaccines for Children Sales by Type (K Units) & (2020-2025)

Table 13. Global Combination Vaccines for Children Sales Share by Type (2020-2025)

Table 14. Global Combination Vaccines for Children Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Combination Vaccines for Children Price by Type (US$/Unit) & (2020-2025)

Table 16. Global Combination Vaccines for Children Sales by Type (K Units) & (2026-2031)

Table 17. Global Combination Vaccines for Children Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Combination Vaccines for Children Price by Type (US$/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Combination Vaccines for Children Sales by Application (K Units) & (2020-2025)

Table 21. Global Combination Vaccines for Children Sales Share by Application (2020-2025)

Table 22. Global Combination Vaccines for Children Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Combination Vaccines for Children Price by Application (US$/Unit) & (2020-2025)

Table 24. Global Combination Vaccines for Children Sales by Application (K Units) & (2026-2031)

Table 25. Global Combination Vaccines for Children Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Combination Vaccines for Children Price by Application (US$/Unit) & (2026-2031)

Table 27. New Sources of Growth in Combination Vaccines for Children Application

Table 28. Global Combination Vaccines for Children Sales by Company (K Units) & (2020-2025)

Table 29. Global Combination Vaccines for Children Sales Share by Company (2020-2025)

Table 30. Global Combination Vaccines for Children Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Combination Vaccines for Children Revenue Share by Company (2020-2025)

Table 32. Global Combination Vaccines for Children by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Combination Vaccines for Children as of 2024)

Table 33. Global Market Combination Vaccines for Children Average Price by Company (US$/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Combination Vaccines for Children, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Combination Vaccines for Children, Product Type & Application

Table 36. Global Key Manufacturers of Combination Vaccines for Children, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Combination Vaccines for Children Sales by Company (2020-2025) & (K Units)

Table 39. North America Combination Vaccines for Children Sales Market Share by Company (2020-2025)

Table 40. North America Combination Vaccines for Children Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Combination Vaccines for Children Revenue Market Share by Company (2020-2025)

Table 42. North America Combination Vaccines for Children Sales by Type (2020-2025) & (K Units)

Table 43. North America Combination Vaccines for Children Sales Market Share by Type (2020-2025)

Table 44. North America Combination Vaccines for Children Sales by Application (2020-2025) & (K Units)

Table 45. North America Combination Vaccines for Children Sales Market Share by Application (2020-2025)

Table 46. Europe Combination Vaccines for Children Sales by Company (2020-2025) & (K Units)

Table 47. Europe Combination Vaccines for Children Sales Market Share by Company (2020-2025)

Table 48. Europe Combination Vaccines for Children Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Combination Vaccines for Children Revenue Market Share by Company (2020-2025)

Table 50. Europe Combination Vaccines for Children Sales by Type (2020-2025) & (K Units)

Table 51. Europe Combination Vaccines for Children Sales Market Share by Type (2020-2025)

Table 52. Europe Combination Vaccines for Children Sales by Application (2020-2025) & (K Units)

Table 53. Europe Combination Vaccines for Children Sales Market Share by Application (2020-2025)

Table 54. China Combination Vaccines for Children Sales by Company (2020-2025) & (K Units)

Table 55. China Combination Vaccines for Children Sales Market Share by Company (2020-2025)

Table 56. China Combination Vaccines for Children Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Combination Vaccines for Children Revenue Market Share by Company (2020-2025)

Table 58. China Combination Vaccines for Children Sales by Type (2020-2025) & (K Units)

Table 59. China Combination Vaccines for Children Sales Market Share by Type (2020-2025)

Table 60. China Combination Vaccines for Children Sales by Application (2020-2025) & (K Units)

Table 61. China Combination Vaccines for Children Sales Market Share by Application (2020-2025)

Table 62. Japan Combination Vaccines for Children Sales by Company (2020-2025) & (K Units)

Table 63. Japan Combination Vaccines for Children Sales Market Share by Company (2020-2025)

Table 64. Japan Combination Vaccines for Children Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Combination Vaccines for Children Revenue Market Share by Company (2020-2025)

Table 66. Japan Combination Vaccines for Children Sales by Type (2020-2025) & (K Units)

Table 67. Japan Combination Vaccines for Children Sales Market Share by Type (2020-2025)

Table 68. Japan Combination Vaccines for Children Sales by Application (2020-2025) & (K Units)

Table 69. Japan Combination Vaccines for Children Sales Market Share by Application (2020-2025)

Table 70. GlaxoSmithKline (GSK) Company Information

Table 71. GlaxoSmithKline (GSK) Description and Business Overview

Table 72. GlaxoSmithKline (GSK) Combination Vaccines for Children Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. GlaxoSmithKline (GSK) Combination Vaccines for Children Product

Table 74. GlaxoSmithKline (GSK) Recent Development

Table 75. Merck（Sanofi） Company Information

Table 76. Merck（Sanofi） Description and Business Overview

Table 77. Merck（Sanofi） Combination Vaccines for Children Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Merck（Sanofi） Combination Vaccines for Children Product

Table 79. Merck（Sanofi） Recent Development

Table 80. Mitsubishi Tanabe Pharma Company Information

Table 81. Mitsubishi Tanabe Pharma Description and Business Overview

Table 82. Mitsubishi Tanabe Pharma Combination Vaccines for Children Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Mitsubishi Tanabe Pharma Combination Vaccines for Children Product

Table 84. Mitsubishi Tanabe Pharma Recent Development

Table 85. KM Biologics Company Information

Table 86. KM Biologics Description and Business Overview

Table 87. KM Biologics Combination Vaccines for Children Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. KM Biologics Combination Vaccines for Children Product

Table 89. KM Biologics Recent Development

Table 90. Walvax Biotechnology Company Information

Table 91. Walvax Biotechnology Description and Business Overview

Table 92. Walvax Biotechnology Combination Vaccines for Children Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Walvax Biotechnology Combination Vaccines for Children Product

Table 94. Walvax Biotechnology Recent Development

Table 95. Biokangtai Company Information

Table 96. Biokangtai Description and Business Overview

Table 97. Biokangtai Combination Vaccines for Children Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Biokangtai Combination Vaccines for Children Product

Table 99. Biokangtai Recent Development

Table 100. Sinovac Company Information

Table 101. Sinovac Description and Business Overview

Table 102. Sinovac Combination Vaccines for Children Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Sinovac Combination Vaccines for Children Product

Table 104. Sinovac Recent Development

Table 105. Production Base and Market Concentration Rate of Raw Material

Table 106. Key Suppliers of Raw Materials

Table 107. Combination Vaccines for Children Distributors List

Table 108. Combination Vaccines for Children Customers List

Table 109. Combination Vaccines for Children Market Trends

Table 110. Combination Vaccines for Children Market Drivers

Table 111. Combination Vaccines for Children Market Challenges

Table 112. Combination Vaccines for Children Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Combination Vaccines for Children Product Picture

Figure 2. Global Combination Vaccines for Children Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Combination Vaccines for Children Sales Market Share by Type in 2024 & 2031

Figure 4. DTaP Product Picture

Figure 5. MMR Product Picture

Figure 6. Others Product Picture

Figure 7. Global Combination Vaccines for Children Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 8. Global Combination Vaccines for Children Sales Market Share by Application in 2024 & 2031

Figure 9. Hospital Examples

Figure 10. Clinic Examples

Figure 11. Other Examples

Figure 12. Global Combination Vaccines for Children Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Combination Vaccines for Children Sales Growth Rate (2020-2031) & (US$ Million)

Figure 14. Global Combination Vaccines for Children Sales (K Units) Growth Rate (2020-2031)

Figure 15. Global Combination Vaccines for Children Price Trends Growth Rate (2020-2031) & (US$/Unit)

Figure 16. Combination Vaccines for Children Report Years Considered

Figure 17. Global Market Combination Vaccines for Children Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 18. Global Combination Vaccines for Children Revenue Market Share by Region: 2020 VS 2024

Figure 19. North America Combination Vaccines for Children Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. North America Combination Vaccines for Children Sales (K Units) Growth Rate (2020-2031)

Figure 21. Europe Combination Vaccines for Children Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. Europe Combination Vaccines for Children Sales (K Units) Growth Rate (2020-2031)

Figure 23. China Combination Vaccines for Children Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. China Combination Vaccines for Children Sales (K Units) Growth Rate (2020-2031)

Figure 25. Japan Combination Vaccines for Children Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. Japan Combination Vaccines for Children Sales (K Units) Growth Rate (2020-2031)

Figure 27. Global Combination Vaccines for Children Revenue Share by Type (2020-2025)

Figure 28. Global Combination Vaccines for Children Sales Share by Type (2026-2031)

Figure 29. Global Combination Vaccines for Children Revenue Share by Type (2026-2031)

Figure 30. Global Combination Vaccines for Children Revenue Share by Application (2020-2025)

Figure 31. Global Combination Vaccines for Children Revenue Growth Rate by Application in 2020 & 2024

Figure 32. Global Combination Vaccines for Children Sales Share by Application (2026-2031)

Figure 33. Global Combination Vaccines for Children Revenue Share by Application (2026-2031)

Figure 34. Global Combination Vaccines for Children Sales Share by Company (2024)

Figure 35. Global Combination Vaccines for Children Revenue Share by Company (2024)

Figure 36. Global 5 Largest Combination Vaccines for Children Players Market Share by Revenue in Combination Vaccines for Children: 2020 & 2024

Figure 37. Combination Vaccines for Children Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 38. Manufacturing Cost Structure of Combination Vaccines for Children

Figure 39. Manufacturing Process Analysis of Combination Vaccines for Children

Figure 40. Combination Vaccines for Children Industrial Chain

Figure 41. Channels of Distribution (Direct Vs Distribution)

Figure 42. Distributors Profiles

Figure 43. Bottom-up and Top-down Approaches for This Report

Figure 44. Data Triangulation

Figure 45. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Combination Vaccines for Children market? zhanKai

The top companies in the global Combination Vaccines for Children market are GlaxoSmithKline (GSK)、Merck（Sanofi）、Mitsubishi Tanabe Pharma.

Related Reports

Global Combination Vaccines for Children Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Combination Vaccines for Children market is projected to grow from US$ 6420 million in 2025 to US$ 10731 million by 2032, at a CAGR of 7.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-31
Pages: 157
USD 4900.00
(Single User License)
Global Combination Vaccines for Children Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Combination Vaccines for Children market size was US$ 6420 million in 2025 and is forecast to reach a readjusted size of US$ 10731 million by 2032 with a CAGR of 7.6% during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 92
USD 4250.00
(Single User License)
Combination Vaccines for Children- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Combination Vaccines for Children was estimated to be worth US$ 6420 million in 2025 and is projected to reach US$ 10731 million, growing at a CAGR of 7.6% from 2026 to 2032.
Published Date: 2026-03-13
Pages: 116
USD 3950.00
(Single User License)
Global Combination Vaccines for Children Market Research Report 2026
The global Combination Vaccines for Children market was valued at US$ 6420 million in 2025 and is anticipated to reach US$ 10731 million by 2032, at a CAGR of 7.6% from 2026 to 2032.
Published Date: 2026-03-13
Pages: 121
USD 2900.00
(Single User License)
Global Combination Vaccines for Children Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Combination Vaccines for Children market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 145
USD 4900.00
(Single User License)
Combination Vaccines for Children- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Combination Vaccines for Children was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 104
USD 3950.00
(Single User License)
Global Combination Vaccines for Children Market Research Report 2025
The global market for Combination Vaccines for Children was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 81
USD 2900.00
(Single User License)
Combination Vaccines for Children- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Combination vaccines for children are vaccines that combine multiple vaccines into a single shot. This allows children to receive protection against multiple diseases with fewer injections, reducing the number of shots they need to receive. Combination vaccines are safe and effective, and are recommended by healthcare providers as part of the routine childhood vaccination schedule. Examples of combination vaccines for children include the DTaP vaccine (which protects against diphtheria, tetanus, and pertussis), the MMR vaccine (which protects against measles, mumps, and rubella), and the Hib vaccine (which protects against Haemophilus influenzae type b).
Published Date: 2024-03-29
Pages: 106
USD 3950.00
(Single User License)
Global and United States Combination Vaccines for Children Market Report & Forecast 2024-2030
Combination vaccines for children are vaccines that combine multiple vaccines into a single shot. This allows children to receive protection against multiple diseases with fewer injections, reducing the number of shots they need to receive. Combination vaccines are safe and effective, and are recommended by healthcare providers as part of the routine childhood vaccination schedule. Examples of combination vaccines for children include the DTaP vaccine (which protects against diphtheria, tetanus, and pertussis), the MMR vaccine (which protects against measles, mumps, and rubella), and the Hib vaccine (which protects against Haemophilus influenzae type b).
Published Date: 2024-03-29
Pages: 107
USD 4350.00
(Single User License)
Global Combination Vaccines for Children Market Research Report 2024
Combination vaccines for children are vaccines that combine multiple vaccines into a single shot. This allows children to receive protection against multiple diseases with fewer injections, reducing the number of shots they need to receive. Combination vaccines are safe and effective, and are recommended by healthcare providers as part of the routine childhood vaccination schedule. Examples of combination vaccines for children include the DTaP vaccine (which protects against diphtheria, tetanus, and pertussis), the MMR vaccine (which protects against measles, mumps, and rubella), and the Hib vaccine (which protects against Haemophilus influenzae type b).
Published Date: 2024-03-29
Pages: 85
USD 2900.00
(Single User License)

Global Combination Vaccines for Children Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Combination Vaccines for Children market is projected to grow from US$ 6420 million in 2025 to US$ 10731 million by 2032, at a CAGR of 7.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-31
Pages: 157
USD 4900.00 (Single User License)
Global Combination Vaccines for Children Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Combination Vaccines for Children market size was US$ 6420 million in 2025 and is forecast to reach a readjusted size of US$ 10731 million by 2032 with a CAGR of 7.6% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 92
USD 4250.00 (Single User License)
Combination Vaccines for Children- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Combination Vaccines for Children was estimated to be worth US$ 6420 million in 2025 and is projected to reach US$ 10731 million, growing at a CAGR of 7.6% from 2026 to 2032.
Published: 2026-03-13
Pages: 116
USD 3950.00 (Single User License)
Global Combination Vaccines for Children Market Research Report 2026
The global Combination Vaccines for Children market was valued at US$ 6420 million in 2025 and is anticipated to reach US$ 10731 million by 2032, at a CAGR of 7.6% from 2026 to 2032.
Published: 2026-03-13
Pages: 121
USD 2900.00 (Single User License)
Global Combination Vaccines for Children Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Combination Vaccines for Children market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 145
USD 4900.00 (Single User License)
Combination Vaccines for Children- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Combination Vaccines for Children was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 104
USD 3950.00 (Single User License)
Global Combination Vaccines for Children Market Research Report 2025
The global market for Combination Vaccines for Children was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 81
USD 2900.00 (Single User License)
Combination Vaccines for Children- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Combination vaccines for children are vaccines that combine multiple vaccines into a single shot. This allows children to receive protection against multiple diseases with fewer injections, reducing the number of shots they need to receive. Combination vaccines are safe and effective, and are recommended by healthcare providers as part of the routine childhood vaccination schedule. Examples of combination vaccines for children include the DTaP vaccine (which protects against diphtheria, tetanus, and pertussis), the MMR vaccine (which protects against measles, mumps, and rubella), and the Hib vaccine (which protects against Haemophilus influenzae type b).
Published: 2024-03-29
Pages: 106
USD 3950.00 (Single User License)
Global and United States Combination Vaccines for Children Market Report & Forecast 2024-2030
Combination vaccines for children are vaccines that combine multiple vaccines into a single shot. This allows children to receive protection against multiple diseases with fewer injections, reducing the number of shots they need to receive. Combination vaccines are safe and effective, and are recommended by healthcare providers as part of the routine childhood vaccination schedule. Examples of combination vaccines for children include the DTaP vaccine (which protects against diphtheria, tetanus, and pertussis), the MMR vaccine (which protects against measles, mumps, and rubella), and the Hib vaccine (which protects against Haemophilus influenzae type b).
Published: 2024-03-29
Pages: 107
USD 4350.00 (Single User License)
Global Combination Vaccines for Children Market Research Report 2024
Combination vaccines for children are vaccines that combine multiple vaccines into a single shot. This allows children to receive protection against multiple diseases with fewer injections, reducing the number of shots they need to receive. Combination vaccines are safe and effective, and are recommended by healthcare providers as part of the routine childhood vaccination schedule. Examples of combination vaccines for children include the DTaP vaccine (which protects against diphtheria, tetanus, and pertussis), the MMR vaccine (which protects against measles, mumps, and rubella), and the Hib vaccine (which protects against Haemophilus influenzae type b).
Published: 2024-03-29
Pages: 85
USD 2900.00 (Single User License)